Google’s AlphaFold, an AI protein-folding software, is helping researchers improve the safety of gene-editing therapies by identifying parts of gene-editing proteins that cause mistakes. Gene editing, which targets specific DNA sequences, faces challenges due to the vast human genome, leading to off-target effects where the wrong DNA is edited. To minimize these errors, scientists use guide RNA to target specific genes and Cas proteins to ensure accuracy. AlphaFold aids in pinpointing areas in these proteins that contribute to errors, allowing researchers to modify them for safer gene-editing therapies. This advancement is crucial as gene editing holds the potential to treat various genetic disorders, but safety remains a top priority.
QUESTION: How might advancements in gene-editing technology impact the future of medicine and healthcare for your generation?
Team uses AlphaFold AI to redesign gene-editing proteins to make them safer
